Sign In
Buy UBS
$47.67
+0.350 (+0.740%)
At Close: Jun 04, 2026
Exclusive: US scrutinizes Russia accounts UBS took over from Credit Suisse, sources say
04:55pm, Tuesday, 12'th Nov 2024
The United States is pursuing an inquiry into Russian clients that UBS took on when it bought Credit Suisse, three people familiar with the matter said, heightening scrutiny of one of the world's bigg
Home Depot in 'great spot' to benefit from multi-year recovery in home improvement: UBS' Lasser
11:26am, Tuesday, 12'th Nov 2024
Michael Lasser, UBS retail analyst, joins 'Squawk on the Street' to discuss if warm weather impacted Home Depot's quarterly earnings results, the gross margin decline for Home Depot, and much more.
United Utilities capex is what to watch, says UBS
09:08am, Tuesday, 12'th Nov 2024
United Utilities kicks off the latest round of water companies updates on Thursday (14 Nov) and UBS says the line to watch for is capital expenditure (capex). “The industry needs to show it is scali
Nvidia's breakneck growth hasn't topped out yet, says UBS
12:06pm, Monday, 11'th Nov 2024
There is scope for the world's most valuable company to become even more valuable, according to the equities experts at UBS. Nvidia Corp, whose bleeding-edge microchips have powered the artificial int
Avanos Medical, Inc. to Present at the UBS Healthcare Conference 2024
04:16pm, Friday, 08'th Nov 2024
ALPHARETTA, Ga. , Nov. 8, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Michael Greiner, interim chief executive officer, will participate in a fireside chat at the UBS
AMGEN TO PRESENT AT THE 2024 UBS GLOBAL HEALTHCARE CONFERENCE
04:00pm, Friday, 08'th Nov 2024
THOUSAND OAKS, Calif. , Nov. 8, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the 2024 UBS Global Healthcare Conference at 10:15 a.m.
Rocket Pharmaceuticals to Participate in the UBS Global Healthcare Conference
07:00am, Friday, 08'th Nov 2024
CRANBURY, N.J.--(BUSINESS WIRE)--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disord
ZURICH--(BUSINESS WIRE)--Regulatory News: UBS AG (NYSE:UBS) (SWX:UBSN) today published its third-quarter 2024 financial report and Pillar 3 report. UBS Group AG previously reported its third-quarter r
Acumen Pharmaceuticals to Participate in the UBS Global Healthcare Conference
04:00pm, Wednesday, 06'th Nov 2024
NEWTON, Mass., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amylo
Merck to Participate in the UBS Global Healthcare Conference
06:45am, Wednesday, 06'th Nov 2024
RAHWAY, N.J.--(BUSINESS WIRE)--Merck to Participate in the UBS Global Healthcare Conference.
EU court dismisses Credit Agricole, Credit Suisse challenges against EU cartel fines
03:49am, Wednesday, 06'th Nov 2024
Europe's second top court on Wednesday dismissed challenges by Credit Suisse (CSAG.UL), now part of UBS , and Credit Agricole against million-euro fines issued by EU antitrust regulators in 2021 for t
United Therapeutics Corporation to Present at the UBS Global Healthcare Conference
04:30pm, Tuesday, 05'th Nov 2024
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that Patrick Poisson, Executive Vice P
Elevance Health Announces Appearance at UBS Global Healthcare Conference
04:05pm, Tuesday, 05'th Nov 2024
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) announced today that senior management is scheduled to present at the UBS Global Healthcare Conference in Rancho Palos Verdes, California on
89bio to Participate in the UBS Global Healthcare Conference
04:05pm, Tuesday, 05'th Nov 2024
SAN FRANCISCO, Nov. 05, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercializat
Boston Scientific to Participate in the 2024 UBS Global Healthcare Conference
08:00am, Tuesday, 05'th Nov 2024
MARLBOROUGH, Mass. , Nov. 5, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in the 2024 UBS Global Healthcare Conference on Tuesday, November 12, 2024.
